Peer-reviewed psychiatric research and validated clinical tools — in one place.
Introduction This study examines how inpatients with catatonia responded when treated with or without antipsychotic medications. It employs two metrics to account for both…
Objective Inflammation has been proposed as a possible mechanism and treatment target for posttraumatic stress disorder (PTSD), but traditional methods for measuring it are…
Background Approximately 30% of patients treated for major depressive disorder develop treatment-resistant depression (TRD). The STAR*D study demonstrated remission rates decline progressively with each…
Over 600 peer-reviewed articles spanning 25 years of psychopharmacology research, for individual clinicians and institutions.
Unlimited access to 600+ peer-reviewed articles from 2001 to present, all new issues and supplements, and unlimited PDF downloads.
IP-authenticated access for libraries, teaching hospitals, health systems, and corporate research teams — with COUNTER 5.1 reporting and a dedicated Librarian Portal.
The Black Book of Psychotropic Dosing and Monitoring stands as the definitive clinical reference guide for healthcare professionals navigating the complex landscape of modern psychopharmacology.
A searchable index of psychotropic medications with mechanisms, indications and monitoring at a glance.
Browse the index →Foundational, evidence-based guides pairing clinical expertise with practical application.
Start learning →Three decades of peer-reviewed rigor — read, cited, and relied upon by clinicians and researchers at the world's leading institutions.
Department chairs and former AJP presidents guide our scientific direction.
Trusted by medical schools, research institutions and industry worldwide.
Every article held to the highest standards of double-blind review.
GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, a new study shows. The large register-based study…
Read More →Salt Lake City, UT — Lipocine Inc. announced positive progress in its pivotal phase 3 clinical trial evaluating…
Bristol Myers Squibb announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation to…
What if the next leap in psychiatric treatment doesn’t come from tweaking dopamine or serotonin, but from reengineering…
Three decades of psychiatric and medical publishing. While these journals are no longer actively published, their archived content represents decades of valuable research and clinical insights.
Reach out for questions about subscriptions, licensing, institutional access, partnership opportunities, or other inquiries.
Contact Us